Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers-论文-万方医学网

首页> > Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

导出原文传递

翻译打印收藏纠错

第一作者： Kim, Sang-A

作者： Kim, Sang-A ^[1] ; Park, Hyejoo ; Kim, Kui-Jin ; Kim, Ji-Won ; Sung, Ji Hea ; Nam, Milang ; Lee, Ju Hyun ; Jung, Eun Hee ; Suh, Koung Jin ; Lee, Ji Yun ; Kim, Se Hyun ; Lee, Jeong-Ok ; Kim, Jin Won ; Kim, Yu Jung ; Kim, Jee Hyun ; Bang, Soo-Mee ; Lee, Jong Seok ; Lee, Keun-Wook

作者单位： Seoul National University (SNU),Seoul Natl Univ ^[1]

关键词 FOLFIRI Cetuximab Capmatinib Hepatocyte growth factor Colorectal cancer COLON-CANCER SOLID TUMORS CELLS ACTIVATION

发布时间 2022-11-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

相似文献

同项目论文

相关期刊

检索历史 清除

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

相似文献

同项目论文

相关期刊

检索历史清除